George Marzouka is a Cardiology physician affiliated with University of Miami. OpenAlex indexes 59 publications with 402 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZenecaProgram year20231 paymentResearch
- AstraZenecaProgram year20211 paymentResearch$15,615openpaymentsdata.cms.gov ↗
- AmgenProgram year20211 paymentResearch
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.2%Beta blocker32%Carvedilol50%Metoprolol Succinate31%Metoprolol Tartrate19%Part D<11 patientsStatin20%Atorvastatin Calcium51%Rosuvastatin Calcium49%Part D<11 patients+ 3 more classes in this area
Blood & clotting
16.9%Factor Xa inhibitor16.9%Eliquis71%Xarelto29%Part D<11 patientsMetabolism & gastrointestinal
4.9%Biguanide (metformin)4.9%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MicroRNA-29c-3p and -126a Contribute to the Decreased Angiogenic Potential of Aging Endothelial Progenitor Cells
International Journal of Molecular Sciences
2025 - HIV-Associated Neurocognitive Disorder (HAND) and Alzheimer’s Disease Pathogenesis: Future Directions for Diagnosis and Treatment
International Journal of Molecular Sciences
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Myron Ginsberg, MD
University of Miami
Carlos Singer, MD
University of Miami
Cynthia Levy, MD
University of Miami
Gwendolyn Scott, MD
University of Miami
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”